VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PUK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PUKPrudential plc
$27.65$34.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPUKQuarterly Financials

Prudential plc (PUK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Prudential plc (PUK) quarterly income statement — complete revenue, gross profit & net income history

PUK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16Q2'16
Revenue11.35B12.68B5.39B4.21B4.41B4.27B4.63B1.91B10.97B8.45B15.17B12.51B31.1B41.37B9.01B12.19B32.76B33.14B29.56B26.67B
Revenue Growth %110.55%201.06%22.27%-1.28%-4.77%123.21%-57.8%-77.38%-27.7%-32.44%-51.22%-69.76%245.27%239.36%-72.51%-63.21%10.82%24.27%172.61%64.79%
Medical Costs & Claims000000000000000-3.83B0-9.78B0-8.87B
Medical Cost Ratio %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-31.4%0%-29.53%0%-33.27%
Gross Profit11.35B05.39B4.21B4.41B4.27B4.63B1.91B10.97B8.45B15.17B12.51B31.1B41.37B9.01B16.02B32.76B42.92B29.56B35.54B
Gross Margin %100%0%100%100%100%100%100%100%100%100%100%100%100%100%100%131.4%100%129.53%100%133.27%
Gross Profit Growth %110.55%-100%22.27%-1.28%-4.77%123.21%-57.8%-77.38%-27.7%-32.44%-51.22%-69.76%245.27%158.27%-72.51%-62.68%10.82%20.77%172.61%119.62%
Operating Expenses8.96B00000001.23B1.06B732.71M1.15B2.08B1.78B1.05B1.24B2.44B2.97B2.5B1.84B
OpEx / Revenue %78.93%0%0%0%0%0%0%0%11.19%12.53%4.83%9.23%6.69%4.3%11.71%10.14%7.45%8.96%8.46%6.9%
Depreciation & Amortization00-8.7B205M161.7M216M77.62M0085M0-13.61M00000000
Combined Ratio %78.93%0%0%0%0%0%0%0%11.19%12.53%4.83%9.23%6.69%4.3%11.71%-21.26%7.45%-20.56%8.46%-26.38%
Operating Income2.39B8.06B5.39B4.21B4.41B4.27B4.63B1.91B9.74B7.39B14.44B11.36B29.02B39.59B7.95B10.95B30.32B30.85B27.06B24.83B
Operating Margin %21.07%63.52%100%100%100%100%100%100%88.81%87.47%95.17%90.77%93.31%95.7%88.29%89.86%92.55%93.08%91.54%93.1%
Operating Income Growth %-55.63%91.23%22.27%-1.28%-4.77%123.21%-52.48%-74.14%-32.53%-34.9%-50.25%-71.31%264.86%261.42%-73.77%-64.49%12.04%24.24%194.19%68.88%
EBITDA2.46B8.04B-3.31B4.42B4.57B4.48B4.71B1.91B9.74B7.48B14.44B11.34B29.02B39.59B7.95B10.95B30.32B30.85B27.06B24.83B
EBITDA Margin %21.7%63.39%-61.44%104.87%103.67%105.06%101.68%100%88.81%88.48%95.17%90.66%93.31%95.7%88.29%89.86%92.55%93.08%91.54%93.1%
Interest Expense70.98M87.75M86.05M67.21M103.07M68.93M101.75M79.46M120.36M118.09M133.26M129.44M181.92M221.85M164.48M143.84M157.54M166.76M155.56M126.81M
Non-Operating Income-70.98M16.14M-5.39B1.1B3.28B2.87B3.17B1.65B8.22B5.91B12.98B10.48B28.17B38.23B21.02B8.45B27.96B28.98B24.06B23.98B
Pretax Income2.39B1.72B2.18B400.28M807.18M978.78M665.08M-1.09B1.12B1.09B1.64B752.17M636.37M1.14B854.84M1.25B1.76B1.7B2.26B717.32M
Pretax Margin %21.07%13.58%40.51%9.5%18.31%22.94%14.37%-56.85%10.23%12.84%10.83%6.01%2.05%2.75%9.49%10.25%5.38%5.14%7.63%2.69%
Income Tax350.46M350.99M399.37M256.31M207.09M233.08M244.86M149.51M275.82M311.58M293.23M250.19M36.23M225.21M161.36M-23.38M878M198.9M1.02B30.32M
Effective Tax Rate %14.66%20.39%18.29%64.03%25.66%23.81%36.82%-13.76%24.59%28.71%17.85%33.26%5.69%19.81%18.88%-1.87%49.8%11.67%45.3%4.23%
Net Income1.99B1.3B2.14B94.93M593.81M743.33M414.44M-1.24B1.46B-2.9B1.17B413.21M-278.55M907.14M1.8B1.86B666.34M1.5B1.01B984.04M
Net Margin %17.56%10.21%39.77%2.25%13.47%17.42%8.95%-64.8%13.27%-34.3%7.74%3.3%-0.9%2.19%19.96%15.28%2.03%4.54%3.4%3.69%
Net Income Growth %-7.06%1264.22%260.92%-87.23%43.28%160%-71.52%57.27%23.92%-801.57%521.6%-54.45%-115.49%-51.31%169.82%23.8%-33.7%52.94%30.16%-
EPS (Diluted)1.540.981.280.070.440.540.30-0.900.620.601.040.380.460.700.560.740.520.920.780.40
EPS Growth %20.31%1316.18%190.91%-87.19%46.67%160%-51.61%-250%-40.38%57.89%126.09%-45.71%-17.86%-5.41%7.69%-19.57%-33.33%130%30%-44.44%
EPS (Basic)1.561.001.280.070.440.540.30-0.900.620.161.040.380.460.700.560.740.520.920.780.40
Diluted Shares Outstanding1.29B1.31B1.36B1.37B1.38B1.37B1.37B1.37B1.33B1.3B1.3B1.3B1.3B646M1.29B643.5M1.29B641.75M1.29B639.75M